It must be an and." Quick summary: Part 2 Reminder of Part 1 Prevalence & Demand: Single largest patient population of any chronic disease in the country Traditionally marginalized groups are more affected by it The numbers are growing Patients want a solution desperately Clinical Efficacy: Clinical trial data suggests benefits outweigh risks for certain patient populations Actions of healthcare providers suggest they strongly want patients to have access Pricing Timeline: Branded drug will start with monopolistic prices for ~decade The patent will eventually expire The bigger the market (outlined above), the more competition, the greater the percentage price decrease Take away from Part 1: over a long enough time period, the price will come down given high demand, regulatory precedent, and economic incentives
Are GLP-1 Agonists Metabolised Through the Liver
When activity decreases, fluid can pool in the lower extremities, particularly the ankles and feet, producing dependent edema that looks and feels like water retention
Do not combine BPC-157 with prescription sleep medications without physician supervision
Either way, the principal is the same
Discuss family planning with your healthcare professional when starting Saxenda treatment